Why are missing quality of life data a problem in clinical trials of cancer therapy?
about
Assessing response bias from missing quality of life data: the Heckman methodThe current practice of handling and reporting missing outcome data in eight widely used PROMs in RCT publications: a review of the current literaturePatient-reported outcomes in randomised controlled trials of prostate cancer: methodological quality and impact on clinical decision makingHealth-related quality of life outcomes associated with four cisplatin-based doublet chemotherapy regimens for stage IVB recurrent or persistent cervical cancer: a Gynecologic Oncology Group study.Identifying type and determinants of missing items in quality of life questionnaires: Application to the SF-36 French version of the 2003 Decennial Health Survey.Inconsistencies in quality of life data collection in clinical trials: a potential source of bias? Interviews with research nurses and trialistsRasch-family models are more valuable than score-based approaches for analysing longitudinal patient-reported outcomes with missing data.Assessment of score- and Rasch-based methods for group comparison of longitudinal patient-reported outcomes with intermittent missing data (informative and non-informative).Can electronic web-based technology improve quality of life data collection? Analysis of Radiation Therapy Oncology Group 0828.Design, implementation and reporting strategies to reduce the instance and impact of missing patient-reported outcome (PRO) data: a systematic review.The Amyotrophic Lateral Sclerosis Assessment Questionnaire (ALSAQ-40): evidence for a method of imputing missing data.Current practices in patient-reported outcome (PRO) data collection in clinical trials: a cross-sectional survey of UK trial staff and managementResults of Database Studies in Spine Surgery Can Be Influenced by Missing Data.Simple imputation methods were inadequate for missing not at random (MNAR) quality of life dataInvestigating the missing data mechanism in quality of life outcomes: a comparison of approaches.Missing data methods for dealing with missing items in quality of life questionnaires. A comparison by simulation of personal mean score, full information maximum likelihood, multiple imputation, and hot deck techniques applied to the SF-36 in the FAn introduction to patient-reported outcome measures in ophthalmic research.The impact of missing trauma data on predicting massive transfusionTime to health-related quality of life score deterioration as a modality of longitudinal analysis for health-related quality of life studies in oncology: do we need RECIST for quality of life to achieve standardization?Missing value imputation in longitudinal measures of alcohol consumption.Quality of life and symptom burden among long-term lung cancer survivorsSequential FOLFIRI.3 + Gemcitabine Improves Health-Related Quality of Life Deterioration-Free Survival of Patients with Metastatic Pancreatic Adenocarcinoma: A Randomized Phase II Trial.Patient reported outcomes as endpoints in medical research.Fatigue, dyspnea, and cough comprise a persistent symptom cluster up to five years after diagnosis with lung cancerSpiritual well-being in lung cancer survivors.The truncation-by-death problem: what to do in an experimental evaluation when the outcome is not always defined.Statistical reviewing for disability and rehabilitation.NCIC Clinical Trials Group experience of employing patient-reported outcomes in clinical trials: an illustrative study in a palliative setting.Patient-reported outcomes in bariatric surgery: a systematic review of standards of reporting.Liver transplantation: a systematic review of long-term quality of life.Acute health-related quality of life in children undergoing stem cell transplant: I. Descriptive outcomes.Evaluation of health-related quality-of-life measures in oncology drug product applications: issues and concerns.Quality of life in chronic lymphocytic leukemia: 5-year results from the multicenter randomized LRF CLL4 trial.Does routinely collected patient-reported outcome data represent the actual case-mix of elective coronary revascularization patients?The prognostic factors and trajectory of HRQOL in patients with pancreatic cancer who received psychiatric intervention.Health-related quality of life after carbon-ion radiotherapy for prostate cancer: a 3-year prospective study.Use of health-related quality of life in prescribing research. Part 2: methodological considerations for the assessment of health-related quality of life in clinical trials.The administration of patient-reported outcome questionnaires in cancer trials: Interviews with trial coordinators regarding their roles, experiences, challenges and training.The importance of patient-reported outcomes in clinical trials and strategies for future optimization
P2860
Q24799249-01AF9708-C090-4AAD-A97E-3757E2D1DB54Q26773044-922F5463-3203-4EB4-966F-482192BDFD40Q26852751-C0B7FD51-43DF-4702-A690-A973F85F850DQ30361969-46A66B8A-A9B8-430F-BB31-175BDAC24EA2Q30493771-1E779975-7964-4EE2-855D-F327211AC215Q30677410-032FB02F-3354-4DBD-ADC8-5101B6F6A97BQ30717231-E2DE41AA-41F4-4FE3-8D3B-A79329FF8C6EQ30762685-27B6BD7B-9B1D-4A21-995E-8417188C5226Q30809152-D02BF345-CBA1-42D3-B00B-1BB840212841Q31108599-08BDC81E-5D76-4344-92E6-337B9B000E83Q31110257-4A5598B1-FBF5-43ED-A271-38CA5A5517AAQ31134502-1C6601C5-A4F0-4758-AC77-07A707435EF7Q31145265-2D78B4A7-703F-4D82-9E06-AC4798183F4FQ31168964-81D903CA-4FFC-40A2-A09D-57F3F6CCB3DFQ33471797-57382FF6-90BA-44F4-83E2-3C27E3D33419Q33706317-4F73AA43-94B5-44B0-B719-24B77319F000Q33759121-47E05F98-3118-44F3-AB62-D16D0DB8A6FAQ34777598-92DAD5F8-A8DF-4BA1-ABD4-BC8457076615Q34807981-FE868F65-0805-4640-81B0-97361ED8070FQ34941467-2B413600-F031-46E5-A475-1F22D11E18E5Q35621522-0A6B2129-CFBA-4CB6-A2E6-373C594F9673Q35641643-95E857D8-3377-4451-A714-F703A8C78D99Q35739677-981281B9-46E7-4143-852D-B55ABC7AF9E5Q36055064-0C1CCCA1-EA38-4263-9F4F-0AE52842220CQ36893333-F61DC699-329A-4F37-A63B-31FA42460FF3Q37102003-25431754-A7A1-4C8B-ABB8-4FEE7BD2A72AQ37209875-8656C801-1425-4218-A9A6-E5968ACE09E4Q37763136-1B24EE65-DF12-4C47-BAE1-0D37B6F76F71Q38103621-70B6ED43-2C46-4F2F-AAE1-5D2172ECFDA2Q38202283-2963F461-7568-433C-B4E5-5F2188FDCF62Q42519418-A569EA1C-1E03-47EC-9956-822E59AD1DDDQ42622536-461FDD3A-22CA-4E7D-9652-0B96E75427E8Q45708911-02A33A58-4C04-4E8E-9E1A-1A6D62A7BEFDQ47239989-0C06CAEE-9841-4C66-969A-65C0F2F85F02Q47954461-71CFFB22-9AB2-4DD5-832A-E592F2CAD120Q48153733-9B531708-41B5-45E7-AA33-3EA71AD33E44Q52958866-07A41576-518B-4233-A166-02B7259AED14Q53281712-25C893D6-39D4-4B5B-8047-826C54402378Q59135171-EEFD59C1-63CF-49E5-AE28-B114A8A0C206
P2860
Why are missing quality of life data a problem in clinical trials of cancer therapy?
description
1998 nî lūn-bûn
@nan
1998 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի մարտին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Why are missing quality of life data a problem in clinical trials of cancer therapy?
@ast
Why are missing quality of life data a problem in clinical trials of cancer therapy?
@en
type
label
Why are missing quality of life data a problem in clinical trials of cancer therapy?
@ast
Why are missing quality of life data a problem in clinical trials of cancer therapy?
@en
prefLabel
Why are missing quality of life data a problem in clinical trials of cancer therapy?
@ast
Why are missing quality of life data a problem in clinical trials of cancer therapy?
@en
P2093
P1476
Why are missing quality of life data a problem in clinical trials of cancer therapy?
@en
P2093
Fairclough DL
Peterson HF
P304
P356
10.1002/(SICI)1097-0258(19980315/15)17:5/7<667::AID-SIM813>3.0.CO;2-6
P407
P577
1998-03-01T00:00:00Z